Vimarsana
Biggest News Aggregation in the World

Page 3 - Brook Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brook Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brook Labs Today - Breaking & Trending Today

BellBrook Labs receives grant to develop drugs for lupus - Vimarsana News

BellBrook Labs receives grant to develop drugs for lupus

Industry News: BellBrook Labs receive NIH grant to treat lupus and related autoimmune diseases The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway 22 Apr 2021 BellBrook Labs has been awarded a $1.8 million Phase II SBIR grant by the National Institute of Allergy and Infectious Diseases (NIAID) to develop lead molecules that block cyclic GAMP synthase (cGAS) for the treatment of lupus and other autoimmune diseases.  BellBrook’s CEO, Dr. Robert Lowery is the principal investigator for the effort, and Dr. Keith Elkon...

BellBrook Labs receives NIH funding for novel approach to stimulating anti-tumor immunity - Vimarsana News

BellBrook Labs receives NIH funding for novel approach to stimulating anti-tumor immunity

Industry News: BellBrook Labs receives NIH funding for novel approach to stimulating anti-tumor immunity 12 Mar 2021 BellBrook Labs has been awarded a $300,000 Phase I Small Business Innovative Research (SBIR) grant to develop and validate HTS assays for the discovery of small-molecule antagonists of TREX1. Immunotherapy approaches such as immune checkpoint blockade are transforming oncology.  However, many patients do not respond to existing agents, and new therapeutic strategies for eliciting immune responses to tumors are badly needed.  It has recently become clear that activation of the...

TR-FRET readout available with Transcreener cGAMP cGAS Assay - Vimarsana News

TR-FRET readout available with Transcreener cGAMP cGAS Assay

Product News: TR-FRET readout now available with the Transcreener cGAMP cGAS Assay With this addition, researchers can more easily screen for small molecule modulators of cGAS 26 Jan 2021 Launched in November 2019, the Transcreener cGAMP cGAS Assay has generated a great deal of interest in the drug discovery community. While fluorescence polarization (FP) readouts offer a stable and robust option, some researchers prefer time-resolved Förster-resonance-energy-transfer (TR-FRET) readouts for large screens. After months of development, BellBrook Labs is pleased to announce the addition of a TR...